Flood Biotech
Specializing in rapid vaccine and anti-bacterial development software and the creation of large interrelated genetic databases
Born from Covid-19
The technology at Flood Biotech was built in response to the Covid-19 pandemic.
Built on NIH Data
Our vaccine and anti-bacterial candidates are built on Genbank data from the National Institute of Health.
Patents
One of our long-term goals is to create a library of prototype patents for vaccines and anti-bacterial drugs based on our research.
Rapid Vaccine Development
Our technology allows us to rapidly develop prototype vaccines and anti-bacterial candidates
Tree of Life
A large interrelated database of genetic samples from NIH databases
FLŌD Database
A real-time database of emerging and existing health threats for government and military planners
Individual Diseases
Focused projects on some of the most problematic disease of our time
One small idea. Global reach.
The idea behind Flood Biotech’s technology is simple, but has great potential for mankind.
Developing vaccine and anti-bacterial candidate prototypes is our main focus.
But we have also begun construction of The Tree of Life — a large interrelated genetic database showing the connections between different organisms.
Another project is the FLŌD (First Line of Defense) Database — a real-time database that will help both military and civilian government planners to deal rapidly with emerging Covid-19 mutations — as well as the pandemics of the future.
We provide medical and scientific research information in the fields of pharmaceuticals and genetics; and consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science.
Covid-19 Vaccine Candidate Development
Rapid computational analysis of NIH Covid-19 full sequences allowed us to create thirty six potential Covid-19 vaccine candidates in just 48 hours.
Number of Vaccine Candidates
Hours of Processing Time
Prototype Patents Granted
Signature Process
Our process was developed out of data analysis tools originally designed for computational finance.
We focus on data analysis so that labs and pharmaceutical companies can get cures to people in the shortest time possible.
Current Projects
Check out some of our current projects below.
Covid-19
36 vaccine candidates.
48 hours of processing time.
3 prototype patents granted
Malaria
In 2018 Malaria killed approximately 400,000 people, mostly in Sub-Saharan Africa.
This is one of our upcoming projects.
Tuberculosis
1.5 million people died of Tuberculosis in 2018.
This is one of our upcoming projects.
A New Player In The Industry
Our goal is simple — to get the output of our technology into labs as quickly as possible.
Our company focuses on prototype vaccine and anti-bacterial candidate generation as well as large interrelated genetic databases for research and military/civilian government planning.
We actively seek partnerships with research institutions, universities, and pharmaceutical companies.
We eventually look to build a super computing environment to leverage the technology to combat viral and antibacterial mutations in real time.
Our goal is not a small one — we want to cure all diseases, and to save the world.
Reach Us
We are always happy to speak with you.
Please note we currenly only work with US-based companies.
info (at) flood.bio